Stay updated on Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial
Sign up to get notified when there's something new on the Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial page.

Latest updates to the Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision tag updated from v3.4.0 to v3.4.1; no visible changes to trial content or navigation in the page screenshot. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check34 days agoChange DetectedThe page now displays the Last Update Posted timestamp, and the Last Update Posted (Estimated) field has been removed.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page shows a minor revision update from v3.3.3 to v3.3.4, with no changes to study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check55 days agoChange DetectedA new label 'Last Update Posted (Estimated)' appears, replacing the former 'Last Update Posted'.SummaryDifference0.0%

- Check62 days agoChange DetectedSite listings updated: Budapest, Hungary (postal code 1044) and Wroclaw, Poland (postal code 51-685) entries were added/updated, replacing the previous Budapest entry (1138). The Last Update field changed from an estimated date (2025-09) to a concrete date (2025-12-22) and now reads 'Last Update Posted'.SummaryDifference0.1%

Stay in the know with updates to Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial page.